pAAV-CMV-SauriCas9 Citations (3)

Originally described in: A compact Cas9 ortholog from Staphylococcus Auricularis (SauriCas9) expands the DNA targeting scope.
Hu Z, Wang S, Zhang C, Gao N, Li M, Wang D, Wang D, Liu D, Liu H, Ong SG, Wang H, Wang Y PLoS Biol. 2020 Mar 30;18(3):e3000686. doi: 10.1371/journal.pbio.3000686. eCollection 2020 Mar. PubMed Journal

---

Articles Citing pAAV-CMV-SauriCas9

Articles
Engineered Staphylococcus auricularis Cas9 with high-fidelity. Wei N, Shang L, Liu J, Wang M, Liu Y, Zhu C, Fei C, Zhang L, Yang F, Gu F. FASEB J. 2023 Aug;37(8):e23060. doi: 10.1096/fj.202202132RR. PubMed
Preclinical evaluation of CRISPR-based therapies for Noonan syndrome caused by deep-intronic LZTR1 variants. Knauer C, Haltern H, Schoger E, Kugler S, Roos L, Zelarayan LC, Hasenfuss G, Zimmermann WH, Wollnik B, Cyganek L. Mol Ther Nucleic Acids. 2024 Jan 23;35(1):102123. doi: 10.1016/j.omtn.2024.102123. eCollection 2024 Mar 12. PubMed
Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation. Zhu W, Du W, Rameshbabu AP, Armstrong AM, Silver S, Kim Y, Wei W, Shu Y, Liu X, Lewis MA, Steel KP, Chen ZY. Sci Transl Med. 2024 Jul 10;16(755):eadn0689. doi: 10.1126/scitranslmed.adn0689. Epub 2024 Jul 10. PubMed

If you have published an article using this material, please email us at to have your article added to this page.